Pharmaceuticals

TONG REN TANG

Tong Ren Tang FY2026 Q1 Earnings Release on April 30 After-Market (BJT)

Tong Ren Tang Technology Announces 2025 Annual Results: Revenue and Profit Decline

TONG REN TANG released FY2025 9 Months Earnings on March 27 (BJT), actual revenue HKD 5.548 B, actual EPS HKD 0.3108

TONG REN TANG released FY2025 Q3 earnings on March 27 (BJT), actual revenue HKD 1.501 B, actual EPS HKD 0.0245

TONG REN TANG released FY2025 earnings on March 27 During-Market (BJT), actual revenue HKD 7.087 B (forecast HKD 8.073 B), actual EPS HKD 0.3381 (forecast HKD 0.4559)

TONG REN TANG released FY2025 Q4 earnings on March 27 During-Market (BJT), actual revenue HKD 1.526 B, actual EPS HKD 0.025

TONG REN TANG to release FY2025 earnings on March 27, during market hours (BJT), with forecast revenue of HKD 7.936 B and EPS of HKD 0.4605

Tong Ren Tang Technology Shareholders Approve Updated Distribution Framework Agreement

Tongrentang Technology Renewed Three-year Land Lease Agreement

Tong Ren Tang Technology Announces Q1-Q3 2025 Earnings

Tong Ren Tang Technology Re-signs Three-year Distribution and Procurement Agreements with Controlling Shareholder

Tong Ren Tang Technology Sees Double Decline in Revenue and Profit in H1 2025

Tong Ren Tang released FY2025 Q1 earnings on August 26, 2025 (BJT) with actual revenue of HKD 2.002 B and EPS of HKD 0.1415

TONG REN TANG released FY2025 Q2 earnings on August 26 During-Market (BJT), actual revenue HKD 2.046 B, actual EPS HKD 0.1422

Tong Ren Tang released FY2025 Semi-Annual Earnings on August 26 During-Market BJT, with actual revenue of HKD 4.048 B and EPS of HKD 0.2863

TONG REN TANG FY2025 Semi-Annual Earnings Release on August 26, 2025 (BJT)

Tongrentang Technology Announces FY2024 Dividend of RMB 0.18 per Share

Tong Ren Tang Science Appoints Chen Fei as Non-Executive Director

Tong Ren Tang Technology Executive Changes

Tong Ren Tang Technology Announces Final Dividend of 0.18 Yuan Per Share for 2024

CH DEMETER FIN

FAMEGLOW

LUEN THAI

NEW GONOW RV

REF HOLDINGS

PARADISE ENT

WEBX HOLDING

HAICHANG HLDG

BEST FOOD HLDG

INTELLIMARK W27

Ordinary dividend (cash)

Ex Date: 2026.06.16, Cash dividend 0.2037 HKD

01666

00570

03613

600085

159849

512010

516500

516930

513060

159929

Recently, the National Chinese Herbal Pieces Alliance Procurement Office released centralized procurement documents, proposing to purchase 41 varieties of Chinese herbal pieces, categorized into two specification grades: selected goods and unified goods. This procurement follows the principles of 'stabilizing clinical use, ensuring quality, opposing internal competition, and preventing bid rigging,' led by the Shandong Medical Security Bureau, and is expected to reshape a market valued at 300 billion yuan

Wallstreetcn

TRAD CHI MED

TONGRENTANGCM

CR Sanjiu

E Fund CSI HK Equities Medical and Health Integration ETF

Taikang CNI Public Health and Medical Health ETF

China Merchants CSI Biotechnology Theme ETF

E Fund CSI 300 Health Care ETF

Guotai SSE STAR Brand Name Drug ETF

ChinaAMC CSI Biotechnology Theme ETF

Yinhua CSI Innovative Drugs Industry ETF

Minsheng Royal CSI Biotechnology Theme ETF

Bosera Hang Seng Health Care ETF(QDII)

Fullgoal Hang Seng SCHK Innovative Drug & Healthcare ETF

Hwabao WP Hang Seng SCHK Innovative Drug Select ETF

GF CSI HK Innovative Drugs Industry ETF(QDII)

ChinaAMC Hang Seng Biotechnology Technology ETF(QDII)

China Universal 800 Health Care ETF

Bosera Hang Seng SCHK Innovative Drug Select ETF

GF CSI All Share Health Care ETF

New Progress in Centralized Procurement of Chinese Herbal Pieces: 41 Varieties Included, 300 Billion Market Landscape to Change

TONG REN TANG announced its 2025 annual performance, with revenue of 6.484 billion RMB, a year-on-year decrease of 10.7%. It recorded a net profit of 396 million RMB, down 24.1%, with earnings per share of 31 cents. The final dividend remains at 18 cents

AASTOCKS

In the "Performance" report, TONG REN TANG announced a full-year net profit of 396 million RMB, a decrease of 24.1%, with a final dividend of 18 cents

01079

Tongrentang Medical and Health has urgently halted its listing plan due to market conditions, resulting in only 4 new stocks being listed next Monday. Deshi performed the best, closing up 94.7%, with a paper profit of HKD 4,685 to HKD 5,025 per lot; Huayan Robotics rose 5.4%, with a paper profit of HKD 182 to HKD 354 per lot. Tongrentang Medical and Health has decided to delay its listing and return the application funds, but remains committed to completing the global offering in a timely manner. Fourier and Copper Master will be listed next Tuesday, both priced at the lower limit of their offering price. Jifei Technology has submitted a listing application, expecting to raise USD 200 million

Stheadline

PINE TECH

4 New stocks in the dark market "report success" with DeShi showing double profits, while HuaYan Robotics only rises by 10%

Tong Ren Tang Technologies Co. Ltd. has proposed a final ordinary cash dividend of RMB 0.18 per share for the financial year ending December 31, 2025, with payment set for August 11, 2026, pending shareholder approval. The company outlined tax treatments for H-share investors, including a 10% corporate income tax for non-resident enterprises and varying individual income tax rates. The latest analyst rating for the stock (HK:1666) is a Hold with a price target of HK$4.50. The company operates in the pharmaceutical sector and adheres to PRC tax regulations.

Tip Ranks

Tong Ren Tang Technologies Proposes Final 2025 Dividend and Outlines Tax Treatment

513700

Beijing Tong Ren Tang Healthcare Investment has postponed its Hong Kong IPO, originally scheduled for Monday, due to unfavorable market conditions. The company aimed to raise up to HK$897.7 million by offering 108.15 million shares. Investor demand was weak, with the public tranche only 4.85 times oversubscribed. Retail and institutional investors will receive refunds by March 30. The firm, part of a larger group known for traditional Chinese medicine, had cleared its listing hearing last year but delayed the offer due to market volatility and concerns over post-listing performance.

SCMP

Penghua CSI HK Connect Health Care Composite ETF

Tong Ren Tang healthcare unit pulls Hong Kong IPO scheduled for Monday

02667

Beijing Tongrentang Healthcare Investment Co., Ltd. (Tongrentang Healthcare, announced the postponement of its global offering and Hong Kong listing plan, citing consideration of the current market environment and other factors. The international underwriting agreement will not be signed, and the underwriting agreement for the Hong Kong public offering will not take effect. The company stated that it remains committed to completing the global offering and listing in due course

TONGRENTANGCARE

Tongrentang Healthcare Postpones Hong Kong IPO, Remains Committed to Timely Completion of Global Offering and Listing

Tong Ren Tang Medical and Health has launched its IPO, planning to raise up to HKD 898 million, with the goal of acquiring and establishing 10 medical institutions by 2029. The company relies on its 300-year-old brand to provide integrated traditional Chinese medicine services, addressing the health management needs arising from China's aging population. The IPO was launched on March 20, with a proposed issuance of 108 million shares, priced between HKD 7.30 and 8.30, and is expected to be listed for trading on March 30

BambooWorks

TRT launches IPO to provide medical and health services relying on its time-honored brand

TONG REN TANG(01666.HK)